you are viewing a single comment's thread.
Totally diferent "animals."OREX's product: popular diet pill (very profitable); AVNR's product: a very limited population (not easy to have profit).OREX has had a partner, Takeda, for marketing (and don't forget the up-front); AVNR was deeply diluted, twice, for marketing cash.
I agree. I think believe both stocks have oversold but OREX has sold off way too much too fast.Looks like a very limited downside for the next 7 weeks.